In 2024, domestic and foreign equity holders sold shares worth over $30 billion via block deals, showcasing sustained ...

In a bid to bolster pandemic preparedness, Sanofi has opened a modular vaccine manufacturing plant in Tuas Biomedical Park, Singapore.

The French pharma firm is seeking to increase insulin production in Beijing as trade tensions between the EU and China simmer ...

Sanofi SA will invest around 1 billion euros ($1.1 billion) to build a new insulin production base in Beijing, its biggest ...

Sanofi plans to invest around US$1.05 billion to build a new insulin production base in Beijing, which will mark the French ...

Sanofi has officially opened a modular biologics manufacturing facility in Singapore that is designed to allow rapid ...

French pharma major Sanofi has added a new plant in Singapore to make vaccines and other medicines, as the company seeks to ...

Clinical trials for a revolutionary vaccine to treat acne will be conducted by the National Skin Centre in partnership with ...

Expansion into Emerging Markets with High Prevalence of Chronic Inflammatory Conditions Presenting Lucrative Opportunities for <a target=_blank hre ...

Sanofi has announced the opening of its new €558m-backed manufacturing facility in Singapore, which the company says ...

Sanofi inaugurated its $800m healthcare manufacturing facility, Modulus, located in Tuas Biomedical Park to be operational in ...

Singapore's and Saudi Arabia's health officials have signed a memorandum of understanding to strengthen health sector ...